Development of a Novel Nanoparticle-Based Drug Delivery System for Targeted Cancer Therapy

Thesis Abstract

Abstract
The field of cancer therapy has witnessed significant advancements over the years, with targeted drug delivery systems emerging as a promising approach to enhance the efficacy and reduce the side effects of anticancer drugs. Nanoparticle-based drug delivery systems have gained considerable attention due to their ability to target specific cancer cells while sparing healthy tissues. This thesis focuses on the development of a novel nanoparticle-based drug delivery system for targeted cancer therapy. Chapter 1 provides a comprehensive introduction to the research, outlining the background of the study, problem statement, objectives, limitations, scope, significance, structure of the thesis, and definition of key terms. The need for targeted drug delivery systems in cancer therapy is emphasized, highlighting the challenges associated with conventional chemotherapy and the potential benefits of nanoparticle-based approaches. Chapter 2 presents a detailed literature review covering ten key aspects related to nanoparticle-based drug delivery systems for cancer therapy. The review encompasses the current state of the art in the field, including different types of nanoparticles, targeting strategies, drug loading methods, and the role of nanoparticles in overcoming multidrug resistance in cancer cells. Chapter 3 discusses the research methodology employed in this study, detailing the experimental design, materials and methods used for nanoparticle synthesis and characterization, in vitro and in vivo evaluation of the drug delivery system, and data analysis techniques. The chapter also addresses ethical considerations and safety measures implemented during the research. Chapter 4 presents a thorough discussion of the findings obtained from the experimental work, focusing on the efficacy and specificity of the developed nanoparticle-based drug delivery system in targeting cancer cells. The chapter also analyzes the release kinetics of the encapsulated drug, cellular uptake mechanisms, cytotoxicity profiles, and potential mechanisms of action involved in the anticancer activity of the nanoparticles. Chapter 5 serves as the conclusion and summary of the thesis, highlighting the key findings, contributions to the field of cancer therapy, limitations of the study, future research directions, and practical implications of the developed nanoparticle-based drug delivery system. The significance of the research in advancing personalized medicine and improving cancer treatment outcomes is underscored. In conclusion, the development of a novel nanoparticle-based drug delivery system for targeted cancer therapy represents a significant stride towards improving the precision, efficacy, and safety of anticancer treatments. This research contributes valuable insights to the field of nanomedicine and holds promise for the development of innovative therapeutic strategies for combating cancer.